Jessika Bertacchini obtained the Degree in 2004, in Pharmaceutical Biotechnology, University of Modena and Reggio Emilia and PhD in 2008, in Human Morphological and Molecular Sciences, University of Bologna, Italy. She had an experience in 2008 as a Visiting Scientist at the George Mason University, Center for Applied proteomics and molecular medicine (Manassas, VA, U.S.A) where she focused her research activity on the Reverse Phase Protein Microarray applied to leukemia blasts. In 2009, she was a Visiting Scientist at the Laboratory of Signal Transduction, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School (Boston, MA, U.S.A), where her research was focused on the characterization of migration ability of cancer prostate cells correlated with Akt isoforms expression. During her scientific training, she won two Scholar-in-training-award: FEBS workshop “Lipids as Regulators of Cell Function” (June 2008); AACR'S San Francisco meeting “Targeting PI3K/mTOR Signaling in Cancer conference” (February 2011). She has 10-years of experience in the field of cellular signaling, focused on PI3K/Akt/mTOR pathway in diverse pathology. Another area of her scientific research is the identification and analysis of novel Akt substrates, by a phospho-proteomic approach. She identified lamin A/C as a nuclear Akt substrate and demonstrated that Akt-mediated lamin A phosphorylation regulates the stability of the precursor, prelamin A. Recently, she won a competition in the Institute of Anatomy, University of Modena and Reggio Emilia, as an Assistant professor and she started to investigate signaling mechanisms involved in bone cell relationships during the various bone processes (osteogenesis, resorption, remodeling); another new topic of interest concerns the cross-talk between bone and muscle cells. As far as the teaching activity is concerned, from 2017, she is the coordinator of the Course of Anatomy and Histology for Obstetrician Degree at the University of Modena and Reggio Emilia, Modena, Italy.